glp 1 patches nausea What to Know Singapore authorities looking into illegal
Description
Presas E, Tovar S, Cuarro J, OShea JP, ODriscoll CM
Mounjaro received FDA approval in May 2022
GLP-1 receptor agonistsincluding semaglutide, liraglutide and dulaglutideare prescribed for type 2 diabetes and obesity management, but costs vary dramatically depending on how you access them
Children under age 18: Semaglutide has not been studied in children so it is unknown whether it is effective and safe in young people
Regular follow-up : Attend scheduled appointments with your GP or diabetes specialist nurse to assess treatment response, adjust doses, and monitor for adverse effects
